Clinical Trial Update: Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Neoadjuvant Compound 121564 with platinum doublet chemotherapy in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Compound 121564

Snippet

Sponsor: Arafat Tfayli | Conditions: Non-Small Cell Lung Cancer Stage | Phase 2 | Status: UNKNOWN